# Glenmark Pharmaceuticals Limited – FDA Inspection, May 20, 2022

Source: https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/3db03adb-b93f-4e9a-8ec6-4f05144e5a4f
Source feed: FDA_Inspections

> FDA inspection 1170118 of Glenmark Pharmaceuticals Limited, May 20, 2022. Classification: Official Action Indicated (OAI). 5 citations under 21 CFR part 211. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1170118
- Company Name: Glenmark Pharmaceuticals Limited
- Inspection Date: 2022-05-20
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5

## Related Documents

- [FDA Inspection 1103081 - 2019-09-27](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/2ecc5ee7-1d47-4269-84ae-e280ac4fbe41)
- [FDA Inspection 1082656 - 2019-03-15](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/76994ec3-3b82-446f-9cf1-7c06892b1e58)
- [FDA Inspection 1011069 - 2017-03-31](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/a5c21800-ad37-4711-9700-04664fe379a5)
- FDA Inspection 885332 - 2014-05-30
- [FDA Inspection 849889 - 2013-07-19](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/d3bf1a09-8a2e-4b48-a074-e7143a83a5d1)

Company: https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/8a329d32-4a7d-4062-8336-1a4c9455759e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
